Ho Jeong Kwon
Yonsei University
Professor
South Korea
-
Chemical biology, Chemical genomics, Chemical proteomics, Organelle interaction, Autophagy
[Education and Training]
1980-1984: BS, Seoul National University; 1990-1992: MS, The University of Tokyo, Dept. of Biotechnology; 1992-1995: PhD, The University of Tokyo, Dept. of Biotechnology; 1995-1998: Post Doc, Harvard University, Dept. of Chemistry and Chemical Biology
[Academic Appointments]
2005-present: Yonsei University, Dept. of Biotechnology, Korea, Professor/Director; 2018-present: Lund University, Dept. of Clinical Sciences, Faculty of Medicine, Sweden, Guest Professor; 2014-present: Yonsei University, College of Medicine, Dept. of Internal Medicine, Professor (Adjunct); 2011-2019: Institute of Pasteur, Korea (IPK), Science Board Member; 2011-2012: Stanford University, Dept. of Chemical & Systems Biology, USA, Visiting Professor; 1999-2005: Sejong University, Dept. of Biotechnology, Korea, Chair of the Department, Assistant/Associate Professor
Y. Jang, M. Ko, JY Lee, JY Kim, E-W Lee, HJ Kwon*, Autophagy (doi: 10.1080/15548627.2025.2519054), (2025)
M. Ko, J. Kim, R. Lazim, JY Lee, JY Kim, V. Gosu, Y. Lee, S Choi, HJ Kwon*, Exp. Mol. Med., 56(12):2714-2725, (2024)
Choi SH, Hwang H, Han S, Eom H, Choi JS, Han S, Lee D, Lee SY, Koo H, Kwon HJ*, Lim YB*, Journal of Controlled Release 366, 104-113 (2024)
Jung Y, Lee SE, Kang I, Cho SM, Kang KS*, Kwon HJ*, Clin Transl Med. 12(4), (2022)
Kwak C., et al, Kwon HJ,* Hong E*, Seo JG,* and Rhee HW*, Cell Chemical Biology 29, 1–15, (2022)
Cho SM, Kim Y, Jung Y, Ko M, Marko-Varga G, Kwon HJ*, J. Med. Chem. (2021)
Kim D, Yang KE, Kim DW, Hwang HY, Kim J, Choi JS, Kwon HJ*, Clin Transl Med. (2021)
Hwang HY, Shim JS, Kim D, Kwon HJ*, Autophagy (2020), doi:10.1080/15548627.2020.1841953
At our lab in Yonsie Univ, we explore the molecular logic of cellular signaling that governs life and disease using small molecules as tools By integrating proteomics, chemical biology, and translational research, we uncover how post-translational modifications and protein networks control cancer progression, metabolic disorders, and stress adaptation. Our interdisciplinary environment bridges fundamental discovery with therapeutic innovation, empowering young scientists to think critically, collaborate globally, and translate molecular insights into medical impact.
